Serum ferritin values in primary care: Are high values overlooked?

Journal of Clinical Pathology

Volumn 63, Issue 12, 2010, Pages 1124-1126

  Ogilvie, Catherine ^a   Fitzsimons, Kathyrn ^a   Fitzsimons, Edward J ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; FATTY LIVER; FEMALE; FERRITIN BLOOD LEVEL; GENERAL PRACTITIONER; HEART VALVE PROSTHESIS; HEMOCHROMATOSIS; HEMOLYSIS; HEPATITIS C; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; AGED; AGING; BIOLOGICAL MARKERS; FEMALE; FERRITINS; HEMOCHROMATOSIS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PRIMARY HEALTH CARE; SCOTLAND; SEX FACTORS;

EID: 78649633623     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.083188     Document Type: Article

References (11)

1. Bryant J, Cooper K, Picot J, et al. Diagnostic strategies using DNA testing for hereditary haemochromatosis in an at risk population; a systematic review and economic evaluation. Health Technol Assess 2009;13:1-148.
2. Delatycki MB, Wolthuizen M, Collins V, et al. Implementation of iron XS: a study of the acceptability and feasibility of genetic screening for hereditary haemochromatosis in high schools. Clin Genet 2010;77:241-8.
3. Worwood M. Ferritin in human tissues and serum. Clin Haematol 1982;11:275-307.
4. Beutler E, Felitti V, Ho N, et al. Relationships of body iron stores to levels of serum ferritin, serum iron, unsaturated iron binding capacity and transferrin saturation in patients with iron storage disease. Acta Haematol 2002;107:145-9.
5. Witte DL. Can serum ferritin be effectively interpreted in the presence of the acute phase response. Clin Chem 1991;37:484-5.
6. Gordeuk VR, Reboussin DM, McLaren CE, et al. Serum ferritin concentrations and body iron stores in a multicentre, multiethnic primary care population. Am J Haematol 2008;83:618-26.
7. Waalen J, Felitti VJ, Gelbart T, et al. Screening for haemochromatosis by measuring ferritin levels: a more effective approach. Blood 2008;111:3373-6.
8. Andersen RV, Tybjaerg-Hansen A, Appleyard M, et al. Haemochromatosis mutations in the general population; iron overload progression rate. Blood 2004;103:2914-19.
9. Olynyk JK, Hagan SE, Cullen DJ, et al. Evolution of untreated hereditary haemochromatosis in the Busselton population; a 17 year study. Mayo Clin Proc 2004;79:309-13.
10. Guyander D, Jacquelinet C, Moirland R, et al. Non invasive prediction of fibrosis in C282Y homozygous haemochromatosis. Gastroenterology 1998;115:929-36.
11. European Association for the Study of the Liver (EASL). EASL clinical practice guidelines for HFE haemochromatosis. J Hepatol. Published Online First: 18 April 2010. doi:10.1016/j.jhep.2010.03.001.